J&J: Potential HIV vaccine falls short in mid-stage study
August 31, 2021 at 16:30 PM EDT
A potential HIV vaccine being developed by Johnson & Johnson did not provide protection against the virus in a mid-stage study, the drugmaker said Tuesday.
